RxSight, Inc. (RXST) NASDAQ

8.43

-0.38(-4.31%)

Updated at October 29 04:00PM

Currency In USD

Valuation

Market Cap1.34B
Enterprise Value1.33B
P/E Ratio-10.65
PEG Ratio0.55
Price/Sales Ratio2.19
Price/Book Ratio1.24
Enterprise/Revenue2.01
Enterprise/EBITDA-8.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.21
Operating Margin-0.27

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.12

Income Statement

Revenue139.93M
Revenue/Share3.86
Gross Profit98.94M
EBITDA-23.76M
Net Income-27.46M
Diluted EPS-0.71

Balance Sheet

Total Cash227.49M
Total Cash/Share5.58
Total Debt11.72M
Total Debt/Equity0.04
Current Ratio13.93
Book Value Per Share6.82

Price History

52-Week Change-83.54
52-Week High55.57
52-Week Low6.32
Moving Average 50 Days8.78
Moving Average 200 Days16.06

Statistics

Average Volume923,148
Shares Outstanding40.92M
% Held by Institutions81.74

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A